论文部分内容阅读
自1947年Watkinson等首先用雄激素治疗再生障碍性贫血(再障)至今近40年,雄激素对慢性再障障的疗效已被国内外多数学者所公认,但不同制剂疗效的差异报告不多。现将我们对大力补去氢甲睾酮和丙酸睾酮(丙睾)的疗效对比分析报告如下。材料与方法 1.一般资料:病例为我院内科1972年2月～1985
Since 1947 Watkinson and other first androgen treatment of aplastic anemia (aplastic anemia) for nearly 40 years, the effect of androgens on chronic aplastic anemia has been recognized by most scholars at home and abroad, but the difference in the efficacy of different preparations reported . Now we strongly add to the hydrogen testosterone and testosterone propionate (testis) comparative analysis of the results reported below. Materials and Methods 1. General Information: The cases of our hospital internal medicine from February 1972 to 1985